SCHEMBL18375655

SCHEMBL18375655

CN(Cc1ccccc1)[C@@H](Cc1ccc(O)cc1)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 13/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2A P28223 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47
OPRD1 P41143 12/20 0.47
OPRM1 P35372 5/20 0.47
MTOR P42345 1/20 0.46
HPGD P15428 1/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
TRPV1 Q8NER1 1/20 0.45
SLC7A5 Q01650 1/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20362254 1.00 OPRK1 (0.47) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL900942 0.93 ADRA2B (0.54) OPRK1ADRA2BADRA2CSLC6A2HTR2A
Trifluoroacetic Acid SCHEMBL13733639 0.86 ADRA2B (0.47) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL7920495 0.82 ACHE (0.50) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL24305664 0.81 OPRK1 (0.44) OPRK1OPRD1OPRM1
Trifluoroacetic Acid SCHEMBL15284675 0.81 ADRA2B (0.43) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL7466902 0.80 NPC1 (0.46) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL17559642 0.80 NPC1 (0.46) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL17161709 0.80 NPC1 (0.46) OPRK1ADRA2BADRA2CSLC6A2HTR2A
SCHEMBL1416482 0.80 NR4A2 (0.58) OPRK1ADRA2BADRA2CSLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11484525-B2 Mu opioid receptor modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-11-01 US disclosed
EP-3319444-B1 MU OPIOID RECEPTOR MODULATORS UNIV CALIFORNIA (US) 2022-03-09 EP disclosed
US-20210052548-A1 MU OPIOID RECEPTOR MODULATORS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-02-25 US disclosed
US-20210052548-A1 MU OPIOID RECEPTOR MODULATORS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-02-25 US disclosed
US-10702498-B2 MU opioid receptor modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-07-07 US disclosed
US-10702498-B2 MU opioid receptor modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-07-07 US disclosed
US-20200109126-A1 MU OPIOID RECEPTOR MODULATORS UNIV CALIFORNIA (US) 2020-04-09 US disclosed
US-20200109126-A1 MU OPIOID RECEPTOR MODULATORS UNIV CALIFORNIA (US) 2020-04-09 US disclosed
EP-3565543-A1 MU OPIOID RECEPTOR MODULATORS The Regents of The University of California (US) 2019-11-13 EP disclosed
US-20190076398-A1 MU OPIOID RECEPTOR MODULATORS Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2019-03-14 US disclosed
US-20190076398-A1 MU OPIOID RECEPTOR MODULATORS Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2019-03-14 US disclosed
WO-2018129393-A1 MU OPIOID RECEPTOR MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-07-12 WO disclosed
WO-2018129393-A1 MU OPIOID RECEPTOR MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-07-12 WO disclosed
WO-2017007695-A1 MU OPIOID RECEPTOR MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11484525-B2 Mu opioid receptor modulators OPRM1, OPRK1, OPRD1 OPRK1 2/4885ADRA2B 22/4885ADRA2C 15/4885
US-10702498-B2 MU opioid receptor modulators OPRM1, OPRK1, OPRD1 OPRK1 2/4885ADRA2B 22/4885ADRA2C 15/4885
US-20190076398-A1 MU OPIOID RECEPTOR MODULATORS OPRM1, OPRK1, OPRD1 OPRK1 2/4885ADRA2B 22/4885ADRA2C 15/4885
US-20210052548-A1 MU OPIOID RECEPTOR MODULATORS OPRM1, OPRK1, OPRD1 OPRK1 2/4885ADRA2B 22/4885ADRA2C 15/4885
US-20200109126-A1 MU OPIOID RECEPTOR MODULATORS OPRM1, OPRK1, OPRD1 OPRK1 2/4885ADRA2B 22/4885ADRA2C 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.